ライフサイエンスコーパス: MAP

1 MAP identified a number of SASs that suppressed pS6 (Ser

2 MAP is successfully applied to predict differential miRN

3 l autonomously and acts in parallel to DLK-1 MAP kinase and EFA-6 pathways.

4 p = 0.02, p = 0.04, p < 0.001 for MAP-UA-15, MAP-FA-15, and MAP-FA-10, respectively.

5 itogenic signaling pathways, like the ERK1/2 MAP kinase pathway, and innate immune signaling.

6 ei (NeuN), microtubule-associated protein-2 (MAP-2) and betaIII-tubulin.

7 High CO(2) above 60% and 5% O(2) MAP effectively prevented melanosis (below 10% for 12 da

8 er efficacy to inhibit melanosis at low O(2) MAP.

9 e MAP-UA-15 (GMT 242.5, 95% CI 133.2-441.5), MAP-FA-15 (GMT 218.6, 95% CI 111.9-427.0), and MAP-FA-10

10 lculated as the depth of hypotension below a MAP of 65 mm Hg (in millimeters of mercury) x time spent

11 millimeters of mercury) x time spent below a MAP of 65 mm Hg (in minutes) divided by total duration o

12 olarity of the embryo and is controlled by a MAP kinase pathway that includes the MAPKKK YODA (YDA).

13 s approach, as we demonstrate by compiling a MAP kinase model.

14 diagnosis of MAP infection, we constructed a MAP protein array with 868 purified recombinant MAP prot

15 s can be up-regulated due to activation of a MAP kinase pathway or inactivation of the tumor suppress

16 ogy, who would benefit from treatment with a MAP kinase pathway inhibitor.

17 via their transmembrane domain, can activate MAP kinases in a ligand-independent manner.

18 In addition, MAPs alter the motility of kinesin and dynein to control

19 ultivalency are sufficient to mimic advanced MAP-like behavior.

20 ions are sufficient to also support advanced MAP functionality.

21 ntly, these inhibitors differentially affect MAP kinase phosphatase activity toward 2P-ERK2.

22 tween TVC-melanosis and TVC-firmness for all MAP mixtures, while CO(2) gave higher efficacy to inhibi

23 rmylase (PDF) and methionine aminopeptidase (MAP).

24 P-FA-15 (GMT 218.6, 95% CI 111.9-427.0), and MAP-FA-10 (GMT 437.1, 95% CI 254.3-751.3) groups compare

25 MT 485.0, 95% CI 301.5-780.2, p = 0.001) and MAP-UA-15 (367.6, 95% CI 197.9-682.7, p = 0.02) groups c

26 sorafenib and inhibitors of MAP kinase 1 and MAP kinase2 had a synergistic antiproliferative effect.

27 .04, p < 0.001 for MAP-UA-15, MAP-FA-15, and MAP-FA-10, respectively.

28 1) ; 95% confidence interval (CI) = 1-9] and MAP (5 mmHg; 95% CI = 1-9) were increased, whereas FVC (

29 by a combined activation of beta-catenin and MAP kinase signaling.

30 ytes in a manner dependent on NF-kappaB- and MAP kinase-activation, which is further enhanced by hypo

31 e interaction between cortical perfusion and MAP was estimated using a linear random slope model and

32 The cAMP-PKA and MAP kinase pathways are essential for plant infection in

33 ationship can be extended to the MAP-RAP and MAP-CrCP relationships, to assess their contribution to

34 such as Ca(2+), reactive oxygen species, and MAP kinases.

35 We applied MAP-C to further explore the biochemical mechanism of th

36 kinase (HvCERK1) and protein kinases such as MAP kinase 3 (HvMPK3) and MAPK substrate 1 (HvMKS1), and

37 rectly activating autophagy and MAP3K5 (ASK)-MAP kinase signaling, E2F1 governs a distinct transcript

38 Here we describe an assay, MAP-C (Mutation Analysis in Pools by Chromosome conforma

39 orylated at an [S/T]PR motif by the atypical MAP kinase ErkB.

40 The atypical MAP kinases ERK3 and ERK4 are activated by phosphorylati

41 artery blood flow ( Q (BA) ), FVC ( Q (BA) /MAP) and MSNA burst frequency were measured continuously

42 rrelation (p-value < 0.05) was found between MAP and tortuosity (medians of Gaussian and mean curvatu

43 on given to the dynamic relationship between MAP and cerebrovascular resistance (CVR).

44 focus on tracking disparities over time; BP MAP will conduct a cluster-randomized trial comparing ef

45 ase 2 upon phosphorylation, thereby bridging MAP kinase and G-Protein-Coupled Receptor signaling.

46 domized 1:1 to vasopressors guided either by MAP target (60-65 mm Hg, permissive hypotension) (n = 12

47 ower doses of influenza vaccine delivered by MAPs.

48 th ease of use and flexibility in mind, capC-MAP is a suit of programs written in C++ and Python, whe

49 We present capC-MAP, a software package for the analysis of Capture-C da

50 Cell-MAP expands cells more than four-fold while preserving t

51 thod for cell super-resolution imaging (Cell-MAP) which preserves cell fluorescence.

52 In addition, Optimized-Cell-MAP completely preserves fluorescence and successfully a

53 Optimized-Cell-MAP further successfully applies to the study of structu

54 useogliflozin (0.9 mg kg(-1)) did not change MAP, HR, RBF, or creatinine clearance (CrCl) in SD rats

55 th modified atmosphere packaging conditions (MAP), in our case, aerobic, vacuum or high O2, to extend

56 Altogether, our results demonstrate MAP-C as a powerful method for dissecting the mechanisti

57 kinetics play a crucial role in determining MAP kinase cascade signaling dynamics and cell fate deci

58 ansport function, via the Wallenda (Wnd)/DLK MAP kinase axonal damage signaling pathway.

59 cologic inhibition of BRAF or the downstream MAP kinase MEK is highly effective in treating BRAF-muta

60 increases phosphorylation of the downstream MAP kinase pathway targets, MAPK11, MAP3K and MAPK1.

61 MAP7 (ensconsin, E-MAP-115) is a ubiquitous MAP that organizes the microtub

62 nitiate pMF by a mechanism that requires ERK-MAP kinase signalling and new BDNF protein synthesis (Q

63 Dicer is phosphorylated by the ERK-MAP kinase pathway and because this pathway is activated

64 Inhibiting BDNF's receptor, TrkB, ERK/MAP kinase activation, or NMDA receptors blocks this att

65 After adjusting for age, gender, ethnicity, MAP, IOP, body mass index (BMI), and presence of diabete

66 In addition, we demonstrate FLOW-MAP analysis of a previously published scRNAseq dataset.

67 facilitate this analysis, we developed FLOW-MAP, a graphical user interface (GUI)-based software too

68 tal datasets for comparison, we perform FLOW-MAP analysis side by side with other single-cell analysi

69 e provide a detailed description of the FLOW-MAP algorithm and how to use the open-source R package F

70 rate when it is advantageous to use the FLOW-MAP approach.

71 For MAP kinase pathway activation in KRAS-mutant cells, the

72 .4-161.8), p = 0.02, p = 0.04, p < 0.001 for MAP-UA-15, MAP-FA-15, and MAP-FA-10, respectively.

73 WHO with additional support from MAP International, American Leprosy Missions, Fondation

74 From these data, we propose a general "MAP code" that has the capacity to strongly bias directe

75 = 34) or standard care (n = 34), with a goal MAP of at least 65 mm Hg in both groups.

76 portant for the stimulation of PKA and Gpmk1 MAP kinase by compounds in wheat spikelets.

77 HD-MAP administration of 2.5 mug HA induced haemagglutinati

78 HD-MAP delivery resulted in enhanced humoral responses comp

79 HD-MAP vaccination was safe and well tolerated; any systemi

80 ity of the influenza vaccine delivered by HD-MAP.

81 The Vaxxas high-density microarray patch (HD-MAP) consists of a high density of microprojections coat

82 ysis of the cellular composition from the HD-MAP application sites.

83 Vaccination using the HD-MAP was safe and well tolerated and resulted in immune r

84 Influenza vaccine coated onto the HD-MAP was stable stored at temperatures up to 40 degrees C

85 Using the HD-MAP, a 2.5 mug dose (1/6 of the standard dose) induced H

86 strains) indicated that, overall, Vaxxas HD-MAP delivery induced immune responses that were similar

87 e report a phase I trial using the Vaxxas HD-MAP to deliver a monovalent influenza vaccine that was t

88 f and participants were blind as to which HD-MAP treatment was administered and to administration of

89 HD-MAPs were coated with a monovalent, split inactivated in

90 of the study and vaccinated with either: HD-MAPs delivering 15 mug of A/Singapore/GP1908/2015 H1N1 H

91 The vaccine coated onto HD-MAPs was antigenically stable when stored at 40 degrees

92 fety and immunological analysis, received HD-MAPs delivering 15 mug HA or uncoated HD-MAPs applied to

93 HD-MAPs delivering 15 mug HA or uncoated HD-MAPs applied to the forearm.

94 Sing) to the volar forearm (FA); uncoated HD-MAPs; intramuscular (IM) injection of commercially avail

95 pants (20 per group) were vaccinated with HD-MAPs delivering doses of 15, 10, 5, 2.5, or 0 mug of HA

96 was lower in patients assigned to the higher MAP target (median: 1.14 mug.72 h/l [interquartile range

97 Patients assigned to the higher MAP target (n = 58) received higher doses of norepinephr

98 and dobutamine (p = 0.01) and reached higher MAPs (86 +/- 9 mm Hg vs. 72 +/- 10 mm Hg, p < 0.001).

99 istiocytosis patients, caused hyperactivated MAP kinase signaling, conferred IL-3 hypersensitivity an

100 iphasic electrograms different from an ideal MAP.

101 d their dynamic response to a step change in MAP was calculated by means of transfer function analysi

102 he CBFV response, following a step change in MAP, was mainly due to the contribution of RAP during bo

103 for detecting pathophysiological changes in MAP and describe a potential diagnostic fingerprint of t

104 n to the dynamic CBFV response to changes in MAP and plays a major role in explaining the deteriorati

105 As a result, MeJA treated garlic cloves in MAP could be stored at 0 degrees C for up to 4 months or

106 capsaicin results in a dose-related rise in MAP and HR that is significantly reduced by a selective

107 tion in a decerebrate mouse causes a rise in MAP and HR which is abolished by dorsal rhizotomy or by

108 of downstream signaling pathways, including MAP kinase and Akt.

109 cantly less or no suppression of LPS-induced MAP kinase and NFkappaB activation was also observed in

110 follow-up after use of aromatase inhibitors (MAP.3 and International Breast Cancer Intervention Study

111 ral different cellular stresses that involve MAP kinase signaling.

112 However, because many known MAPs inhibit branch formation, it is not clear which MAP

113 BQ-123 reduced leg MAP at rest (-8 +/- 4 mmHg; P < 0.001) and lower intensi

114 ctions of three kinesins and a cross-linking MAP that are known to have effects in maintaining MT org

115 Species from low-MAP environments exhibited more negative K(leaf) P(50) a

116 tolerance in Caragana species adapted to low-MAP environments.

117 By contrast, the association between lower MAP and higher mortality was constant across body mass i

118 We found that lower MAP was strongly associated with reduced functional dive

119 on and herbivore removal at sites with lower MAP and higher T.q.wet.

120 Premorbid low admissions had lower MAPs (vs.

121 Lung-MAP (S1400) met its goal to quickly address biomarker-dr

122 Lung-MAP (S1400) was created to establish an infrastructure f

123 Lung-MAP (S1400) was done within the National Clinical Trials

124 With these changes, Lung-MAP continues to meet its goal to focus on unmet needs i

125 The Lung Cancer Master Protocol (Lung-MAP; S1400) is a completed biomarker-driven master proto

126 CT02154490, and all research related to Lung-MAP (S1400) is completed.

127 n-dependent serine protein kinase) and Madd (MAP kinase-activating death domain).

128 Thus, in contrast to many MAPs, the HsCKK domain can differentiate subtly specific

129 hereas phosphorylation of the upstream MAPKs MAP kinase kinase 3 (MKK3) and MKK6, was virtually undet

130 ways, including adhesion, cell wall-mediated MAP kinase signaling, hypersensitivity to host-derived o

131 ons of our computational model using a multi-MAP, in vitro microtubule dynamics assay to reconstitute

132 Natural MAPs, however, show a more sophisticated functionality b

133 neuronal-associated gene expression of NeuN, MAP-2, betaIII-tubulin in addition to growth-associated

134 The neuronal MAP tau is also not sensitive to tubulin acetylation, bu

135 The capability of MAP to explore metabolic profiles at the single-cell lev

136 ify reliable antigens for early diagnosis of MAP infection, we constructed a MAP protein array with 8

137 tial utility for the early sero-diagnosis of MAP infection.

138 The frequencies of MAP kinase kinase kinase kinase 3 [also named germinal c

139 ighly specific, brain-penetrant inhibitor of MAP kinase-interacting kinases resets the translation of

140 e combination of sorafenib and inhibitors of MAP kinase 1 and MAP kinase2 had a synergistic antiproli

141 te its many practical uses, the mechanism of MAP signal generation and the reason it is so different

142 scWB reports increased phosphorylation of MAP kinases (ERK1/2, p38) under hypertonic conditions.

143 personalized MAP scores as the proportion of MAP beats predicting each end point.

144 We show that the reaction of MAP on ribosome-bound nascent chains approaches diffusio

145 range 21-70 years, 36 women), recordings of MAP (Finometer), CBF velocity (CBFV; transcranial Dopple

146 n and metastasis genes and (v) regulation of MAP Kinase Signalling Pathway.

147 e protein is implicated in the regulation of MAP kinase-controlled processes involved in mating, fila

148 wever, progress in controlling the spread of MAP infection has been impeded by the lack of reliable d

149 Further, we dissect how combinations of MAPs affect motors and unveil MAP9 as a positive modulat

150 The microtubule-binding domains of MAPs are structurally divergent, but often depend on ele

151 rials who were randomized to MAP 65 mm Hg or MAP 80/85 to 100 mm Hg targets during the first 36 h aft

152 p38 without simultaneously activating other MAP kinases in neuronal and endocrine cells.

153 The discovery of BRAF mutations and of other MAP kinase pathway alterations, as well as the co-occurr

154 ng property, which is not observed for other MAPs, can prevent branch retraction caused by laser-indu

155 ism mediated by MAP7 to cooperate with other MAPs and control microtubule stability during axonal bra

156 nfected C57BL/6 mice with doramapimod, a p38 MAP-kinase inhibitor, results in reduced inflammation, g

157 endothelial cells via NPR-A binding and p38 MAP kinase activation.

158 ative stress, along with reduced JNK and p38 MAP kinase activity.

159 tate tumorigenesis while increasing bFGF-p38 MAP kinase signaling, beta-catenin-HIF-1alpha expression

160 Both p38 MAP kinase stimulation and an intact autophagy machinery

161 lammatory cytokines, and is regulated by p38 MAP kinase signalling in vitro.

162 Specifically, B. neotomae induced p38 MAP kinase phosphorylation and autophagy in a type IV se

163 et expression, early NF-kappaB, and late p38 MAP kinase phosphorylation, with the latter being indisp

164 s requires Epac2-dependent activation of p38 MAP kinase, which posed the important question of how Ep

165 ay, either with direct inhibitors of the p38 MAP kinase or a small-molecule therapeutic that also inh

166 ophila, where chemical inhibition of the p38 MAP kinase pathway and autophagy factor depletion failed

167 t in the presence of an inhibitor of the p38 MAP kinase pathway.

168 We find that the p38 MAP kinase PMK-3, which is required for the differentiat

169 vious in vitro studies revealed that the p38 MAP kinase signaling pathway coordinates several inflamm

170 tress in airway epithelial cells through p38 MAP kinase-c-Jun signaling and drives senescence by inhi

171 e receptor activation of ERK1/2 and p38alpha MAP kinases and is critical for regulating immune respon

172 bility research consortium assay) and by PA, MAP, and TSP in the <10 mum fraction (inhalation-ingesti

173 res efficient modified atmosphere packaging (MAP).

174 eping quality of modified atmosphere packed (MAP) peeled garlic cloves during storage at 0 degrees an

175 Mycobacterium avium subsp. paratuberculosis (MAP) in cattle and other ruminants.

176 Microarray patches (MAPs) offer the possibility of improved vaccine thermost

177 miniature individual assay of permeability (MAP).

178 -level predictions, we computed personalized MAP scores as the proportion of MAP beats predicting eac

179 thod, termed metabolic activity phenotyping (MAP), to probe metabolic fluxes by utilizing multiplexed

180 PA), hydroxyapatite, monoammonium phosphate (MAP), triple super phosphate (TSP), and bone meal biocha

181 gae effector HopAI known to inactivate plant MAP kinases in M. oryzae.

182 e individuals to MUTYH-associated polyposis (MAP), and the most commonly observed mutation in some MA

183 The monophasic action potential (MAP) is a near replica of the transmembrane potential re

184 sites with higher mean annual precipitation (MAP) and temperature of the wettest quarter (T.q.wet).

185 ted to a range of mean annual precipitation (MAP) conditions and growing in a common garden.

186 500 mm and 60 mm mean annual precipitation (MAP).

187 long gradients of mean annual precipitation (MAP).

188 el achieved a higher mean average precision (MAP) (0.23 versus 0.19, P-value<1e-4) in a de novo cross

189 ecall curves [measured by average precision (MAP): 0.28 versus 0.23, P-value < 0.0001].

190 se the MiRNA-disease Association Prediction (MAP) method, an in-silico method to predict and prioriti

191 0.003) and were maintained nearest premorbid MAPs while receiving vasopressors (P < 0.001).

192 t a universal target-mean arterial pressure (MAP) >65 mm Hg.

193 relationship between mean arterial pressure (MAP) and cerebral blood vessels' diameters and tortuosit

194 defined by a rise in mean arterial pressure (MAP) and heart rate (HR) in response to exercise and is

195 interaction study of mean arterial pressure (MAP) and pulse pressure (PP) in 129 913 individuals in s

196 ion was defined as a mean arterial pressure (MAP) below 65 mm Hg for at least 1 minute.

197 olic, diastolic, and mean arterial pressure (MAP) correlations.

198 The measured mean arterial pressure (MAP) exhibited measurable deviation from baseline 2-4 we

199 etermine the optimal mean arterial pressure (MAP) in patients with AMI and shock after cardiac arrest

200 Mean arterial pressure (MAP) was defined as diastolic BP plus 1/3 (systolic BP -

201 d pressure (DBP) and mean arterial pressure (MAP) were significantly (P < 0.05) reduced with extract

202 IOP, mean arterial pressure (MAP), and HR increased rapidly and significantly by 27%,

203 olic blood pressure, mean arterial pressure (MAP)], brachial artery blood flow ( Q (BA) ), FVC ( Q (B

204 edian SBP (+11%) and mean arterial pressure (MAP, +10%, both p < 0.001), and a unique temporal patter

205 emorrhage to a mean arterial blood pressure (MAP) of 30 mmHg from t = 40-70 min, followed by reperfus

206 le imaging and mean arterial blood pressure (MAP) recording.

207 al heart-level mean arterial blood pressure (MAP) were continuously recorded, in addition to incidenc

208 pressed by the mean arterial blood pressure (MAP)-cerebral blood flow (CBF) relationship, with little

209 dden change in mean arterial blood pressure (MAP).

210 evaluated by multiplexed activity profiling (MAP), an unbiased platform which assays multiple biologi

211 , called male-specific aggression-promoting (MAP) neurons in males and fpC1 in females, control dimor

212 an Msb2-dependent mitogen-activated protein (MAP) kinase (HOG2) and an APSES transcription factor (ST

213 inal kinase (JNK) mitogen-activated protein (MAP) kinase and Fos and Jun transcription factors, may s

214 inal kinase (JNK) mitogen-activated protein (MAP) kinase and the transcription factors Fos and Jun (A

215 asurements of the mitogen-activated protein (MAP) kinase ERK2 have shown that activation by dual phos

216 inhibition of the mitogen-activated protein (MAP) kinase extracellular signal-regulated kinase (ERK)

217 dentified the p38 mitogen-activated protein (MAP) kinase pathway and autophagy machinery as both a li

218 species (ROS) and mitogen-activated protein (MAP) kinase phosphorylation, but exhibited normal respon

219 is facilitated by mitogen-activated protein (MAP) kinase-activated protein kinase 2 (MK2) but is inhi

220 by activation of mitogen-activated protein (MAP) kinases and nuclear factor kappa B and decreased my

221 vation of the JNK mitogen-activated protein (MAP) kinases or the pseudokinase TRB3 by the ER stress s

222 ponses, including mitogen-activated protein (MAP) kinases, NF-kappaB signaling, or cell migration.

223 Microtubule-associated protein (MAP) 2 has been perceived as a static cytoskeletal prote

224 (AD), tau, a microtubule-associated protein (MAP), becomes hyperphosphorylated, aggregates, and accum

225 ing AUG8, which is an MT-associated protein (MAP).

226 Microtubule-associated proteins (MAPs) are a functionally highly diverse class of protein

227 phorylating microtubule-associated proteins (MAPs) of the MAP2/Tau family, but also contribute to the

228 Microtubule-associated proteins (MAPs) regulate microtubule polymerization, dynamics, and

229 n-enzymatic microtubule-associated proteins (MAPs) to demonstrate that MAPs exhibit distinct influenc

230 cts of four microtubule-associated proteins (MAPs), namely EB1, XMAP215, CLASP2, and MCAK, can promot

231 egulated by microtubule-associated proteins (MAPs).

232 e a modified magnified analysis of proteome (MAP) method for cell super-resolution imaging (Cell-MAP)

233 For this purpose, MAPs structurally support microtubules, modulate their d

234 , we describe a method to simulate realistic MAP and intermediate forms, which are multiphasic electr

235 protein array with 868 purified recombinant MAP proteins, and screened a total of 180 well-character

236 Moreover, we demonstrate a reduced MAP response to VRS using TRPV1 antagonism or in Trpv1 n

237 ubunits-show advanced, biologically relevant MAP-like behavior: starPEG-(KA7)(4) binds microtubules i

238 ting trained support vector machine revealed MAP morphologies that, using in silico modeling, reveale

239 ortem brain samples collected within the ROS/MAP and Mayo Clinic RNA-Seq studies.

240 SRF chromatin occupancy by actin signaling, MAP kinases, and MRTFs.

241 The median inter-site MAP variability was 6mmHg with an interquartile range (I

242 the most commonly observed mutation in some MAP populations is Y165C.

243 that the inducible nuclear dual-specificity MAP kinase phosphatase (MKP) DUSP2, a known regulator of

244 CXCL12(1) > CXCL12 stabilized MAP and reduced fluid requirements.

245 s reduced (0 W, 40%; P < 0.05), but systemic MAP was defended by an increased cardiac output.

246 Among SZ MAP-IR(low) subjects, mean DSD was significantly lower t

247 est patients with shock after AMI, targeting MAP between 80/85 and 100 mm Hg with additional use of i

248 e abundance increased with greater long-term MAP along the spatial gradient from arid to mesic grassl

249 ased along the spatial gradient of long-term MAP, and significant effects only occurred at the mesic

250 e MAPK scaffold (CST5), and the two terminal MAP kinases (CEK1/CEK2).

251 -positive results can be minimized, and that MAP sensitivity to thrombin-induced increase in monolaye

252 Experiments demonstrated that MAP is inversely related to cerebral blood vessel diamet

253 We further demonstrated that MAP was more robust than the label-free Raman methods an

254 pressors in T cell lymphoma and suggest that MAP-kinase kinase (MEK) inhibitors combined with ALK inh

255 ombin-induced junction disassembly, and that MAPs carrying such cells can be separated effectively by

256 sociated proteins (MAPs) to demonstrate that MAPs exhibit distinct influences on the motility of the

257 These results indicate that MAPs are suitable for high-throughput experimentation an

258 The MAP and intermediate forms reside on a continuum of sign

259 The MAP method applies a network diffusion approach, startin

260 pha via its canonical receptor CXCR4 and the MAP kinase ERK5.

261 ocyte growth factor receptor (c-MET) and the MAP kinase pathway component B-Raf, providing a proof of

262 to show that dual inhibition of JAK and the MAP kinase pathway provided enhanced therapeutic efficac

263 FgSR is phosphorylated by the MAP kinase FgHog1, and the phosphorylated FgSR interacts

264 f the IKKalpha kinase that is induced by the MAP kinases BRAF and TAK1 and promotes tumor growth inde

265 al Cell, Nichols et al. (2019) establish the MAP kinase ErkB as a critical component for chemotaxis s

266 a significant contribution to explaining the MAP-CBFV relationship.

267 fulfilled the criteria for inclusion in the MAP cohort.

268 r titres were also observed at day 22 in the MAP-FA-10 (GMT 485.0, 95% CI 301.5-780.2, p = 0.001) and

269 geometric mean titres (GMTs) at day 8 in the MAP-UA-15 (GMT 242.5, 95% CI 133.2-441.5), MAP-FA-15 (GM

270 and showed a significant improvement of the MAP (0.29 versus 0.23, P-value<1e-4).

271 eptic mice may result from inhibition of the MAP kinase and NF-kappaB signaling pathways.

272 eover, these data identify activation of the MAP kinase pathway in microglia as a cause of neurodegen

273 Recurrent mutational activation of the MAP kinase pathway in plasma cell myeloma implicates gro

274 This dysregulation of the MAP kinase pathway results in increased CTNNB1, increase

275 s that were over-represented in genes of the MAP kinase pathway.

276 ics screen suggest that intersections of the MAP kinase pathways and autophagy machinery are critical

277 a significantly decreased activation of the MAP kinases ERK1/2 in FGF-2-stimulated cell lines of aff

278 Transfer function analysis of the MAP-CBFV relationship can be extended to the MAP-RAP and

279 in kinase C (PKC), activates in parallel the MAP-kinase and FAK/Yes-associated protein pathways.

280 witches that initiate signalling through the MAP kinase cascade to control cellular proliferation, di

281 aces G(s) and induces signalling through the MAP kinase pathway(2).

282 MAP-CBFV relationship can be extended to the MAP-RAP and MAP-CrCP relationships, to assess their cont

283 Applying this approach to MAP kinase 6 (MKK6), which activates the p38 subfamily o

284 ; NCT02698917) trials who were randomized to MAP 65 mm Hg or MAP 80/85 to 100 mm Hg targets during th

285 tide sequences for the occurrence of typical MAP-like behavior.

286 MAP7 (ensconsin, E-MAP-115) is a ubiquitous MAP that organizes the microtubule cytoskeleton in mitos

287 e, we show that MAP7, a less-well understood MAP that is localized to branch junctions, provides a ke

288 Using MAP-C, we show that inducible interchromosomal pairing b

289 The proposed framework was validated using MAP and MRA data collected from 15 patients over a 700-d

290 ence indicates dynamic functions for various MAPs in activity-dependent synaptic plasticity.

291 ed a viral host-dependency epistasis map (vE-MAP) of 356 human genes linked to HIV function, comprisi

292 complex, CNOT, is a central player in the vE-MAP and show that knockout of CNOT1, 10, and 11 suppress

293 The vE-MAP provides an expansive view of the genetic dependenci

294 The vE-MAP represents a generic platform that can be used to st

295 We recorded 5706 ventricular MAPs in 42 patients with coronary artery disease and lef

296 ibit branch formation, it is not clear which MAP is responsible for regulating microtubule stability

297 here 136 loci significantly associated with MAP and/or PP.

298 ith MAP < 1,250 mm and four wet forests with MAP > 1,400 mm).

299 precipitation by 25% (three dry forests with MAP < 1,250 mm and four wet forests with MAP > 1,400 mm)

300 le stability, dynamics, and interaction with MAPs and motors in a specific manner, widely known as tu